Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 7/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.47 |
| ▸ | PLA2G1B | P04054 | 3/20 | 0.41 |
| ▸ | ATG4B | Q9Y4P1 | 3/20 | 0.41 |
| ▸ | THRA | P10827 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30764098 | 1.00 | ZDHHC20 (0.58) | ZDHHC20EPHX2HCAR2PLA2G1BATG4B | |
| SCHEMBL30764117 | 1.00 | ZDHHC20 (0.58) | ZDHHC20EPHX2HCAR2PLA2G1BATG4B | |
| SCHEMBL30764050 | 1.00 | ZDHHC20 (0.58) | ZDHHC20EPHX2HCAR2PLA2G1BATG4B | |
| SCHEMBL30764054 | 1.00 | ZDHHC20 (0.58) | ZDHHC20EPHX2HCAR2PLA2G1BATG4B | |
| SCHEMBL30764048 | 1.00 | ZDHHC20 (0.58) | ZDHHC20EPHX2HCAR2PLA2G1BATG4B | |
| SCHEMBL5361154 | 1.00 | ZDHHC20 (0.58) | ZDHHC20EPHX2HCAR2PLA2G1BATG4B | |
| SCHEMBL30764090 | 1.00 | ZDHHC20 (0.58) | ZDHHC20EPHX2HCAR2PLA2G1BATG4B | |
| SCHEMBL5361151 | 1.00 | ZDHHC20 (0.58) | ZDHHC20EPHX2HCAR2PLA2G1BATG4B | |
| SCHEMBL30764107 | 1.00 | ZDHHC20 (0.58) | ZDHHC20EPHX2HCAR2PLA2G1BATG4B | |
| SCHEMBL30764039 | 1.00 | ZDHHC20 (0.58) | ZDHHC20EPHX2HCAR2PLA2G1BATG4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912831-B2 | Hydroxyethylpyrrolidone ethacrylate/glycidyl ethacrylate copolymers | ISP INVESTMENTS LLC (US) | 2024-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912831-B2 | Hydroxyethylpyrrolidone ethacrylate/glycidyl ethacrylate copolymers | MMAB, PCNA, HMBS | ZDHHC20 4590/4885EPHX2 105/4885HCAR2 332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.